Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin

BACKGROUND: COVID-19 has been associated with a high prevalence of myocardial injury and increased cardiovascular morbidity. Copeptin, a marker of vasopressin release, has been previously established as a risk marker in both infectious and cardiovascular disease. PURPOSE: Investigate the prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, C K, Ahmed, A A, Kassem, M K, Freynhofer, M F, Jaeger, B J, Aicher, G A, Equiluz-Bruck, S E, Spiel, A S, Vafai-Tabrizi, F V, Gschwantler, M G, Fasching, P F, Wojta, J W, Giannitsis, E G, Huber, K H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767585/
http://dx.doi.org/10.1093/eurheartj/ehab724.3393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767585/
http://dx.doi.org/10.1093/eurheartj/ehab724.3393

Ejemplares similares